全球止血剂市场，2025-2029年

全球止血剂市场预计从 2024 年到 2029 年将成长 9.109 亿美元，预测期内复合年增长率为 5.8%。

本报告对全球止血剂市场进行了全面分析，包括市场规模和预测、趋势、成长要素和挑战，以及对约 25 家公司的供应商分析。

该报告对当前市场状况、最新趋势和驱动因素以及整体市场环境进行了最新分析，其驱动因素包括外科手术数量的增加、对研发的日益重视以及运动相关损伤和脊柱疾病发病率的上升。

本研究采用客观的方法，结合一手和二手讯息，包括来自主要行业相关人员的意见。报告包含全面的市场规模数据、区域細項分析、供应商格局以及对主要企业的分析。报告提供历史数据和预测数据。

研究指出，医院和手术中心的增加是未来几年推动全球止血剂市场成长的主要因素之一。此外，人们越来越重视有效控製手术患者的出血，新兴市场对先进止血剂的需求不断增长，预计也将显着提升市场需求。

目录

第一章执行摘要

第二章 Technavio 分析

• 价格、生命週期、顾客购买篮、采用率和购买标准分析
• 投入与差异化因素的重要性
• 混淆来源
• 驱动因素和挑战的影响

第三章 市场情势

• 市场生态系统
• 市场特征
• 价值链分析

第四章 市场规模

• 市场定义
• 市场区隔分析
• 2024年市场规模
• 2024-2029年市场展望

第五章 市场规模表现

• 2019-2023年全球止血剂市场
• 2019-2023年医药产业细分市场分析
• 2019-2023年产品类型细分市场分析
• 2019-2023年最终用户细分市场分析
• 2019-2023年区域细分市场分析
• 2019-2023年国家细分市场分析

第六章 定性分析

• 人工智慧的影响：全球止血剂市场

第七章五力分析

• 五力分析概述
• 买方的议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

8. 按配方进行市场区隔

• 比较：按配方
• 基质凝胶
• 座垫
• 海绵
• 粉末
• 按配方分類的市场机会

9. 依产品类型进行市场区隔

• 比较：依产品类型
• 基于凝血酶的止血剂
• 明胶基止血剂
• 胶原蛋白蛋白止血剂
• 按产品类型分類的市场机会

第十章 按最终用户进行市场细分

• 比较：按最终用户
• 医院
• 门诊手术中心（ASC）
• 专科诊所
• 按最终用户分類的市场机会

第十一章 客户情况

第十二章 区域情势

• 区域细分
• 区域比较
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚洲
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
• 世界其他地区
  • 巴西
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 土耳其
  • 阿根廷
  • 哥伦比亚
  • 南非
  • 以色列
• 各区域的市场机会

第十三章：驱动因素、挑战与机会

• 市场驱动因素
• 市场挑战
• 驱动因素和挑战的影响
• 市场机会

第十四章 竞争格局

• 概述
• 竞争格局
• 令人困惑的局面
• 产业风险

第十五章 竞争分析

• 公司简介
• 企业排名指数
• 公司市场定位
• Aegis Lifesciences Pvt. Ltd.
• Artivion Inc.
• Axio Biosolutions Pvt. Ltd.
• B.Braun SE
• Baxter International Inc.
• Becton Dickinson and Co.
• CuraMedical BV
• Grayline Medical Inc.
• Johnson and Johnson Services
• MBP Medical Biomaterial Products GmbH
• STERIS plc
• Ted Pella Inc.
• Towne Brothers Pvt. Ltd.
• World Precision Instruments
• Ydm Corp.

第十六章附录

The global hemostats market is forecasted to grow by USD 910.9 mn during 2024-2029, accelerating at a CAGR of 5.8% during the forecast period. The report on the global hemostats market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing volume of surgical procedures performed, rising focus on research and development, increasing incidence of sports-related injuries and spinal ailments.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global hemostats market is segmented as below:

By Formulation

• Matrix and gels
• Sheet and pad
• Sponge
• Powder

By Product Type

• Thrombin-based hemostats
• Gelatin-based hemostats
• Collagen-based hemostats

By End-User

• Hospitals
• ASCs
• Specialty clinics

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rise in number of hospitals and surgical centers as one of the prime reasons driving the global hemostats market growth during the next few years. Also, rising focus on effective blood loss management in patients during surgeries and growing adoption of advanced hemostats in emerging markets will lead to sizable demand in the market.

The report on the global hemostats market covers the following areas:

• Global hemostats market sizing
• Global hemostats market forecast
• Global hemostats market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global hemostats market vendors that include Aegis Lifesciences Pvt. Ltd., Artivion Inc., Axio Biosolutions Pvt. Ltd., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., CuraMedical BV, Gelita AG, Grayline Medical Inc., Integra LifeSciences Corp., Johnson and Johnson Services, MBP Medical Biomaterial Products GmbH, Pfizer Inc., STERIS plc, Ted Pella Inc., Teleflex Inc., Towne Brothers Pvt. Ltd., World Precision Instruments, Ydm Corp.. Also, the global hemostats market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Formulation
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

• 5.1 Global Hemostats Market 2019 - 2023
  • Historic Market Size - Data Table on Global Hemostats Market 2019 - 2023 ($ million)
• 5.2 Formulation segment analysis 2019 - 2023
  • Historic Market Size - Formulation Segment 2019 - 2023 ($ million)
• 5.3 Product Type segment analysis 2019 - 2023
  • Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
• 5.4 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 The AI impact on Global Hemostats Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition

8 Market Segmentation by Formulation

• 8.1 Market segments
• 8.2 Comparison by Formulation
• 8.3 Matrix and gels - Market size and forecast 2024-2029
• 8.4 Sheet and pad - Market size and forecast 2024-2029
• 8.5 Sponge - Market size and forecast 2024-2029
• 8.6 Powder - Market size and forecast 2024-2029
• 8.7 Market opportunity by Formulation
  • Market opportunity by Formulation ($ million)

9 Market Segmentation by Product Type

• 9.1 Market segments
• 9.2 Comparison by Product Type
• 9.3 Thrombin-based hemostats - Market size and forecast 2024-2029
• 9.4 Gelatin-based hemostats - Market size and forecast 2024-2029
• 9.5 Collagen-based hemostats - Market size and forecast 2024-2029
• 9.6 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Hospitals - Market size and forecast 2024-2029
• 10.4 ASCs - Market size and forecast 2024-2029
• 10.5 Specialty clinics - Market size and forecast 2024-2029
• 10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • 12.3.1 US - Market size and forecast 2024-2029
  • 12.3.2 Canada - Market size and forecast 2024-2029
  • 12.3.3 Mexico - Market size and forecast 2024-2029
• 12.4 Europe - Market size and forecast 2024-2029
  • 12.4.1 Germany - Market size and forecast 2024-2029
  • 12.4.2 UK - Market size and forecast 2024-2029
  • 12.4.3 France - Market size and forecast 2024-2029
  • 12.4.4 Italy - Market size and forecast 2024-2029
  • 12.4.5 Spain - Market size and forecast 2024-2029
  • 12.4.6 The Netherlands - Market size and forecast 2024-2029
• 12.5 Asia - Market size and forecast 2024-2029
  • 12.5.1 China - Market size and forecast 2024-2029
  • 12.5.2 India - Market size and forecast 2024-2029
  • 12.5.3 Japan - Market size and forecast 2024-2029
  • 12.5.4 South Korea - Market size and forecast 2024-2029
  • 12.5.5 Indonesia - Market size and forecast 2024-2029
  • 12.5.6 Thailand - Market size and forecast 2024-2029
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • 12.6.1 Brazil - Market size and forecast 2024-2029
  • 12.6.2 Saudi Arabia - Market size and forecast 2024-2029
  • 12.6.3 UAE - Market size and forecast 2024-2029
  • 12.6.4 Turkey - Market size and forecast 2024-2029
  • 12.6.5 Argentina - Market size and forecast 2024-2029
  • 12.6.6 Colombia - Market size and forecast 2024-2029
  • 12.6.7 South Africa - Market size and forecast 2024-2029
  • 12.6.8 Israel - Market size and forecast 2024-2029
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Growing volume of surgical procedures performed
  • Rising focus on research and development
  • Increasing incidence of sports-related injuries and spinal ailments
• 13.2 Market challenges
  • Dearth of medical personnel skilled in effective use of hemostat products
  • High cost of surgical procedures
  • Clinical and other limitations associated with hemostat products
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities
  • Rise in number of hospitals and surgical centers
  • Rising focus on effective blood loss management in patients during surgeries
  • Growing adoption of advanced hemostats in emerging markets

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Aegis Lifesciences Pvt. Ltd.
  • Aegis Lifesciences Pvt. Ltd. - Overview
  • Aegis Lifesciences Pvt. Ltd. - Product / Service
  • Aegis Lifesciences Pvt. Ltd. - Key offerings
  • SWOT
• 15.5 Artivion Inc.
  • Artivion Inc. - Overview
  • Artivion Inc. - Business segments
  • Artivion Inc. - Key offerings
  • Artivion Inc. - Segment focus
  • SWOT
• 15.6 Axio Biosolutions Pvt. Ltd.
  • Axio Biosolutions Pvt. Ltd. - Overview
  • Axio Biosolutions Pvt. Ltd. - Product / Service
  • Axio Biosolutions Pvt. Ltd. - Key offerings
  • SWOT
• 15.7 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key news
  • B.Braun SE - Key offerings
  • SWOT
• 15.8 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
  • SWOT
• 15.9 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.10 CuraMedical BV
  • CuraMedical BV - Overview
  • CuraMedical BV - Product / Service
  • CuraMedical BV - Key offerings
  • SWOT
• 15.11 Grayline Medical Inc.
  • Grayline Medical Inc. - Overview
  • Grayline Medical Inc. - Product / Service
  • Grayline Medical Inc. - Key offerings
  • SWOT
• 15.12 Johnson and Johnson Services
  • Johnson and Johnson Services - Overview
  • Johnson and Johnson Services - Business segments
  • Johnson and Johnson Services - Key news
  • Johnson and Johnson Services - Key offerings
  • Johnson and Johnson Services - Segment focus
  • SWOT
• 15.13 MBP Medical Biomaterial Products GmbH
  • MBP Medical Biomaterial Products GmbH - Overview
  • MBP Medical Biomaterial Products GmbH - Product / Service
  • MBP Medical Biomaterial Products GmbH - Key offerings
  • SWOT
• 15.14 STERIS plc
  • STERIS plc - Overview
  • STERIS plc - Business segments
  • STERIS plc - Key news
  • STERIS plc - Key offerings
  • STERIS plc - Segment focus
  • SWOT
• 15.15 Ted Pella Inc.
  • Ted Pella Inc. - Overview
  • Ted Pella Inc. - Product / Service
  • Ted Pella Inc. - Key offerings
  • SWOT
• 15.16 Towne Brothers Pvt. Ltd.
  • Towne Brothers Pvt. Ltd. - Overview
  • Towne Brothers Pvt. Ltd. - Product / Service
  • Towne Brothers Pvt. Ltd. - Key offerings
  • SWOT
• 15.17 World Precision Instruments
  • World Precision Instruments - Overview
  • World Precision Instruments - Product / Service
  • World Precision Instruments - Key offerings
  • SWOT
• 15.18 Ydm Corp.
  • Ydm Corp. - Overview
  • Ydm Corp. - Product / Service
  • Ydm Corp. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations